latest newsRead more...
19
Aug 2017Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis
Medivir AB and Ascletis today announce that Ascletis has licensed the exclusive rights to develop manufacture and commercialize Medivirs nucleotide polymerase inhibitor for hepatitis C MIV Ascletis code ASC in Greater China Under the terms of the agreement Medivir received an upfront payment and is…
19
Aug 2017Teva Announces Exclusive Launch of Generic Axiron® in the United States
Teva Pharmaceutical Industries Ltd today announced the launch of generic Axiron testosterone topical solution CIII mg mL in the US Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low or no testosterone due to certain medical conditions It…
18
Aug 2017Hikma Announces New Licensing Agreement With Takeda
Hikma Pharmaceuticals PLC the multinational pharmaceutical group today announces that through its wholly owned subsidiary Hikma Pharmaceuticals LLC it has agreed to expand its licensing and distribution agreement with Takeda Pharmaceutical Company Limited Takeda a global research and developmentdriven pharmaceutical company adding new products to…
press releasesRead more...
19
Aug 2017Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 Antibody Discovered Using the OmniAb® Technology
Ligand Pharmaceuticals Incorporated announces that it will receive a million payment from WuXi Biologics subsequent to their licensing of exclusive rights to the antiPD antibody GLS to Arcus Biosciences in…
18
Aug 2017Roving Surgical Robot to Tour 4 Key Andhra Pradesh Cities
Business Wire IndiaA da Vinci Surgical Robot mounted on vehicle in OdishaCancer is a relentless disease Damaging organs and tissues in its wake cancer can be insidious in its onset…
18
Aug 2017New Global Systems Director appointed at Matcon Ltd.
We are pleased to announce the appointment of Andre Goodson as our new Global Systems Director Andre will use his wealth of commercial leadership experience to bring fresh ideas to…
EventsRead more...
22-24
Aug 2017CPhI Korea 2017
UBM
Hall D, COEX Convention and Exhibition Centre
28-29
Aug 2017Pharma CMI
Biotrains
Mumbai
TOP ARTICLES
-
1
Antimicrobial Stewardship Prioritising Quality Access to Healthcare
Antimicrobials treatments that kill or inhibit the growth of microorganisms are effective and necessary in medicine However organisms and microbes have increasi..
-
2
Nanotechnology-based Inhalation Treatment for Lung Cancer
The lungs are the primary organ of the respiratory system The respiratory system works with the circulatory system to deliver oxygen from the lungs to the cells..
-
3
Improving Biopharma Productivity through Optimal Bioreactor Operation
Generating global revenue of US billion biopharmaceuticals account for one fifth of pharmaceutical market The revenue grows at per cent annually which is doubl..
-
4
Parenteral Preparations
INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..
-
5
The Impact of Materials Handling on Facility Design and Operation
Materials handling a fundamental decision All too often the design of pharmaceutical OSD production facilities fails to recognise the impact on and the oppo..
-
6
Untapped Opportunities in Southeast Asia
Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years With a population of about million and a total area of m..
Knowledge Bank
-
Interviews
Datwyler Pharma Packaging
Senior Manager Global Scientific Affairs
Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..
-
Articles
Antimicrobial Stewardship Prioritising Quality Access to Healthcare
Antimicrobials treatments that kill or inhibit the growth of microorganisms are effective and necessary in medicine However organisms and microbes have increasingly begun to resist antimicrobial agents through evolutionary change and mutations Resistance to antimicrobials creates a difficult path for infectious disease medicine because it becomes harder and harder to treat resistant microbes While…
-
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to investigate the efficacy and safety of afatinib an irreversible ErbB family inhibitor alone and in combination with vinorelbine…
-
Case Studies
Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime WGS with routine MTBC diagnostic workflows Methods We compared…
-
Techno Trends
New Method for Residual Solvent Characterization by GC-VUV
A new method has been announced by VUV Analytics for residual solvent testing in pharmaceutical products and excipients that significantly reduces analysis time while improving testing throughput It allows the combination of various sample types into a single test The gas chromatography Vacuum Ultraviolet GCVUV spectroscopy method reduces the GC separation time recommended by the Unites States Pharmacopeia USP Method…
-
White Papers
Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward ascending regions such as India and China to…
-
Industry Reports
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
Sanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration pain and cancer as well as diagnostic products based on contrast media The companys product portfolio includes radiological products including an array of xray imaging…
Advisory Board
Editorial Section
-
Strategy
Failing Data Integrity Audit is not an Option
The timetomarket of blooming Asian pharmaceutical companies especially from India and China are being slowed by the increasing concerns of global and local regulators over data integrity How can they meet regulators audit expectation on data integrity and provide assurance…
-
Research development
Reviving Pharma R&D Productivity with New Modalities
The pharmaceutical industry is facing a decline in RD productivity However genomics biomarkers and access to human tissue samples are offering a range of well validated but challenging biological targets To seize the opportunity leveraging New Modalities and abolishing silos…
-
Clinical Trails
Patient Recruitment
To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…
-
Manufacturing
Added Costs for Added Protections
The Impact of Implementing Safety Features in Pharmaceutical Packaging and Labelling Serialization Unique Device Identification UDI and aggregation catalyse a paradigm shift for the entire industry and are already impacting the pharmaceutical supply chain In…
-
Information Technology
Electronic FDA Submissions
If your time to you is worth savin then you better start swimmin or youll sink like a stone for the times they are a changin Bob Dylan
-
Expert Talk
The Asian Healthcare Market
The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…